Teva Pharmaceutical Industries | TEVA - Net Income

Stock Price
9,215.00
Daily Change
-55.00 -0.59%
Monthly
1.21%
Yearly
65.83%
Q2 Forecast
8,997.46

Teva Pharmaceutical Industries reported $480M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Aspen Pharmacare ZAR 1.47B 4.94B Dec/2025
Cipla INR 6.76B 6.75B Dec/2025
Dr.Reddys Laboratories INR 12.1B 2.27B Dec/2025
Guangzhou Baiy CNY -326.94M 1.12B Dec/2025
Jiangsu Hengrui CNY 2.28B 322.38M Mar/2026
Kalbe Farma IDR 656.41B 241.76B Sep/2025
Richter Gedeon HUF 43.35B 8.49B Sep/2025
Sh Fosun Pharma CNY 847.27M 25.94M Dec/2025
Sun Pharmaceuticals INR 33.69B 2.51B Dec/2025
Teva Pharmaceutical Industries USD 480M 47M Dec/2025